Western Blotting Detection Kit

ECL Advance is a proprietary new substrate licensed exclusively to Amersham by Lumigen, Inc. (Southfield, MI, USA). A feature called Advance Blocking Agent controls backgrounds and ensures a high level of signal intensity. Antibody concentrations can also be reduced to previously unmatched levels, allowing stocks of these potentially valuable preparations to be conserved.

‘With optimized reagents, ECL Advance offers both the highest sensitivity chemiluminescent Western blotting and the ability to reduce the concentration of antibody, thereby saving on the cost and supply of these valuable resources,” said Pieter Noordeloos, vice president marketing, proteomics, Amershambiosciences. The company says the ECL Advance is up to 10 times more sensitive than other chemiluminescent Western Blotting detection kits.